Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ARSI |
| Upstream (Parents) |
|---|
| (<<) ADAM12 → ARSI |
| (<<) BMP1 → ARSI |
| (<<) CDH11 → ARSI |
| (<<) EFEMP2 → ARSI |
| (<<) GLI3 → ARSI |
| (<<) INHBA → ARSI |
| (<<) ITGA5 → ARSI |
| (<<) MN1 → ARSI |
| (<<) NNMT → ARSI |
| (<<) PRKCDBP → ARSI |
| (<<) RPL26L1 → ARSI |
| (<<) THY1 → ARSI |
| Downstream (Children) |
|---|
| ARSI → ACTC1 (>>) |
| ARSI → ADAM8 (>>) |
| ARSI → BCAR1 (>>) |
| ARSI → BCAR3 (>>) |
| ARSI → BPGM (>>) |
| ARSI → CDKN1A (>>) |
| ARSI → COL13A1 (>>) |
| ARSI → DEPDC7 (>>) |
| ARSI → ELFN1 (>>) |
| ARSI → FKSG2 (>>) |
| ARSI → GNB5 (>>) |
| ARSI → INF2 (>>) |
| ARSI → KIAA1199 (>>) |
| ARSI → LIF (>>) |
| ARSI → MMP1 (>>) |
| ARSI → MMP10 (>>) |
| ARSI → MMP28 (>>) |
| ARSI → MYO1E (>>) |
| ARSI → NBL1 (>>) |
| ARSI → NDST1 (>>) |
| ARSI → NFATC4 (>>) |
| ARSI → ODZ2 (>>) |
| ARSI → PLK3 (>>) |
| ARSI → PROCR (>>) |
| ARSI → ROR2 (>>) |
| ARSI → S100A2 (>>) |
| ARSI → SCG5 (>>) |
| ARSI → SOCS3 (>>) |
| ARSI → TPM2 (>>) |
| ARSI → UPP1 (>>) |
